Cytovant Sciences Co., Ltd. Alternatives & Competitors
12 companies similar to Cytovant Sciences Co., Ltd. — Cytovant is a biopharmaceutical company dedicated to developing novel and innova...
Companies similar to Cytovant Sciences Co., Ltd.
T Cell Nouveau
Clinical stage biopharmaceutical company with novel TCR like CAR-T cell therapy for solid...
Tokyo, Japan
SELLAS Life Sciences Group, Inc.
A late-stage clinical biopharmaceutical company focused on developing novel therapies for...
New York, United States
Elpiscience Biopharmaceuticals
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-gener...
Shanghai, China
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
Boston, United States
Rival Readout
Competing with Cytovant Sciences Co., Ltd.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
MEI Pharma
Committed to the development of novel, best-in-class, cancer therapies intended to provide...
San Diego, United States
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Canada
Epsilogen Ltd
Harnessing the power of IgE
United Kingdom
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
South San Francisco, Unit...
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
Compass Therapeutics Inc.
We are developing next-generation antibodies into transformative cancer therapies that imp...
Boston, United States
About Cytovant Sciences Co., Ltd.
Cytovant Sciences Co., Ltd. is a clinical-stage biopharmaceutical company with a mission to develop novel cellular therapeutics uniquely suited to Asian patients. Launched in April 2019 by ROIVANT SCIENCES, the company is headquartered in Hong Kong with offices in Shanghai and Beijing, China.
Biopharmaceutical Company, Cellular Therapeutics, Asia, Clinical-stage, Cell Therapy, TCR-T, Solid Tumor Targeting, Immunological Characteristics, Medigene AG, NY-ESO-1-targeted TCR-T Therapy, License Agreement, Oncology, Innovative Medicines
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cytovant Sciences Co., Ltd.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cytovant Sciences Co., Ltd. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
